(NYSE: TFX) Teleflex's forecast annual revenue growth rate of 4.84% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.49%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.86%.
Teleflex's revenue in 2024 is $3,007,838,000.On average, 13 Wall Street analysts forecast TFX's revenue for 2024 to be $145,845,449,399, with the lowest TFX revenue forecast at $145,156,733,062, and the highest TFX revenue forecast at $146,158,450,878. On average, 13 Wall Street analysts forecast TFX's revenue for 2025 to be $154,557,520,232, with the lowest TFX revenue forecast at $153,150,686,246, and the highest TFX revenue forecast at $157,372,413,260.
In 2026, TFX is forecast to generate $163,304,410,890 in revenue, with the lowest revenue forecast at $160,629,645,275 and the highest revenue forecast at $166,355,362,538.